Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mycodern Spolka Akcyjna specializes in medical innovations, particularly in dermatology and fungal infection treatments. The company combines advanced research with state-of-the-art production to create effective healthcare solutions. Its commitment to addressing unmet medical needs has positioned it as a trusted name in the biotechnology industry. Mycodern aims to improve patient outcomes through innovative and accessible treatments for skin-related conditions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Mycodern Spolka Akcyjna. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-04-08 15:20
Share Issue/Capital Change
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Share Issue/Capital Change
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Related Party Transaction
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Prospectus
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Related Party Transaction
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB
2023-12-31 20:02
Major Shareholding Notification
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 183.3 KB
2023-12-31 20:02
Major Shareholding Notification
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
Polish 181.8 KB
2023-12-31 20:02
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
Polish 637 bytes
2023-12-29 22:27
Prospectus
MCD - dokument ofertowy (seria E)
Polish 444.1 KB
2023-12-29 22:27
Report Publication Announcement
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 728 bytes
2023-11-29 14:02
Prospectus
MCD - Dokument ofertowy
Polish 400.2 KB
2023-11-29 14:02
Share Issue/Capital Change
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.5 KB
2023-10-23 21:09
Share Issue/Capital Change
Formularz zapisu - seria E
Polish 168.3 KB
2023-10-23 21:09
Prospectus
Dokument Ofertowy - seria E
Polish 353.1 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN